Breast Cancer Awareness: Survivor shares what's next
Published . Updated .
Breast Cancer Awareness: Survivor shares what's next KMPH Fox 26
Directly affected
- No company is named in this report.
Indirectly affected
- LMT Lockheed Martin
Defense contractors get more work when conflict spending rises
- RTX RTX
Defense contractors get more work when conflict spending rises
- NOC Northrop Grumman
Defense contractors get more work when conflict spending rises
- GD General Dynamics
Defense contractors get more work when conflict spending rises
- ITA iShares U.S. Aerospace & Defense
A fund of aerospace and defense companies
- BA Boeing
Defense and aerospace orders move with conflict spending
- LHX L3Harris
Defense contractors get more work when conflict spending rises
- HII Huntington Ingalls
Shipyards benefit when naval spending rises
- XAR SPDR SERIES TRUST
Material security escalation can alter defense demand expectations and risk premia.
- NAMS NEW AMSTERDAM PHARMA CO ORDINARY SHARES
GA selected NAMS as a RELATED security because its canonical security name directly matches this event's themes: pharma, shares. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
Price reaction, T-5 to T+3
Breast Cancer Awareness: Survivor shares what's next KMPH Fox 26
Source: KMPH Fox 26
IShares U.S. Aerospace & Defense ETF (ITA) since this story, compared with the market
Since the first closing price after “Breast Cancer Awareness: Survivor shares what's next,” IShares U.S. Aerospace & Defense ETF (ITA) is +1.74%. The S&P 500 fund (SPY) is -1.47% over the same days, a +3.21% difference versus the market. industrial stocks (XLI) is -1.14%, a +2.89% difference versus that group of stocks.
| Company | When | Move | Status |
|---|---|---|---|
| BA | that day | -0.50% | final price |
| BA | the next day | -2.05% | final price |
| BA | two days later | -3.08% | final price |
| BA | three days later | -0.90% | final price |
| BA | three days earlier | -1.13% | final price |
| BA | five days earlier | +1.20% | final price |
| GD | that day | +1.14% | final price |
| GD | the next day | +0.35% | final price |
| GD | two days later | +0.99% | final price |
| GD | three days later | +1.70% | final price |
| GD | three days earlier | -1.46% | final price |
| GD | five days earlier | +0.12% | final price |
| HII | that day | -0.20% | final price |
| HII | the next day | -2.61% | final price |
| HII | two days later | -0.05% | final price |
| HII | three days later | +1.02% | final price |
| HII | three days earlier | -1.48% | final price |
| HII | five days earlier | +0.73% | final price |
| IShares U.S. Aerospace & Defense ETF (ITA) | that day | -0.28% | final price |
| IShares U.S. Aerospace & Defense ETF (ITA) | the next day | -1.26% | final price |
| IShares U.S. Aerospace & Defense ETF (ITA) | two days later | -1.17% | final price |
| IShares U.S. Aerospace & Defense ETF (ITA) | three days later | +0.09% | final price |
| IShares U.S. Aerospace & Defense ETF (ITA) | three days earlier | -1.47% | final price |
| IShares U.S. Aerospace & Defense ETF (ITA) | five days earlier | +0.06% | final price |
| LHX | that day | +0.50% | final price |
| LHX | the next day | -0.97% | final price |
| LHX | two days later | +0.23% | final price |
| LHX | three days later | +1.50% | final price |
| LHX | three days earlier | -1.37% | final price |
| LHX | five days earlier | +0.02% | final price |
IShares U.S. Aerospace & Defense ETF (ITA) filings in this defense story
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Companies in defense around IShares U.S. Aerospace & Defense ETF (ITA)
Companies carried with this story
- ITA IShares U.S. Aerospace & Defense ETF
For “Breast Cancer Awareness: Survivor shares what's next,” IShares U.S. Aerospace & Defense ETF (ITA) is linked, with no stored direction, medium confidence. Reason on file: Material security escalation can alter defense demand expectations and risk premia
- XAR Spdr Series Trust
In “Breast Cancer Awareness: Survivor shares what's next,” Spdr Series Trust (XAR) is linked, with no stored direction, medium confidence. Reason on file: Material security escalation can alter defense demand expectations and risk premia
- NAMS NewAmsterdam Pharma Co N.V
For “Breast Cancer Awareness: Survivor shares what's next,” NewAmsterdam Pharma Co N.V (NAMS) is linked, with no stored direction, medium confidence. Reason on file: GA selected NAMS as a RELATED security because its canonical security name directly matches this event's themes: pharma, shares. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- ACHC Acadia Healthcare
In “Breast Cancer Awareness: Survivor shares what's next,” Acadia Healthcare (ACHC) is linked, with no stored direction, medium confidence. Reason on file: GA selected ACHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- ASND Ascendis Pharma A/S
Ascendis Pharma A/S (ASND) is linked, with no stored direction, medium confidence in the 12 Oct 2026 story “Breast Cancer Awareness: Survivor shares what's next.” Reason on file: GA selected ASND as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- ATYR aTYR PHARMA
In “Breast Cancer Awareness: Survivor shares what's next,” aTYR PHARMA (ATYR) is linked, with no stored direction, medium confidence. Reason on file: GA selected ATYR as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- BBIO BridgeBio Pharma
BridgeBio Pharma (BBIO) is linked, with no stored direction, medium confidence in the 12 Oct 2026 story “Breast Cancer Awareness: Survivor shares what's next.” Reason on file: GA selected BBIO as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- CRDF Cardiff Oncology
For “Breast Cancer Awareness: Survivor shares what's next,” Cardiff Oncology (CRDF) is linked, with no stored direction, medium confidence. Reason on file: GA selected CRDF as a RELATED security because its canonical security name directly matches this event's themes: oncology. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
How “Breast Cancer Awareness: Survivor shares what's next” reaches IShares U.S. Aerospace & Defense ETF (ITA)
The 12 Oct 2026 story “Breast Cancer Awareness: Survivor shares what's next” names IShares U.S. Aerospace & Defense ETF (ITA) because of Defense.
The link for IShares U.S. Aerospace & Defense ETF (ITA) is this: Material security escalation can alter defense demand expectations and risk premia
Spdr Series Trust (XAR) is here too. Its reason reads: Material security escalation can alter defense demand expectations and risk premia
Dates in the story, and the IShares U.S. Aerospace & Defense ETF (ITA) price range
ITA traded between 201.08 and 217.79 across 20 sessions. The latest close on file is 207.60. NAMS traded between 19.58 and 25.10 across 20 sessions. The latest close on file is 20.49. XAR traded between 216.28 and 245.40 across 20 sessions. The latest close on file is 223.20.
What the saved facts support for IShares U.S. Aerospace & Defense ETF (ITA)
46 out of 100
“Breast Cancer Awareness: Survivor shares what's next” scores 46 out of 100. The score uses 1 sources, and 11 linked companies.